Pizon, Anna Claire .

HRN: 15-45-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2023
CEFUROXIME 500MG (TAB)
02/25/2023
03/04/2023
ORAL
500mg/tab
BID
S/P 1° LTCS Thickly MSAF
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes